In this edition:
– Apolipoprotein A1 infusions after acute MI
– TAVI in patients with high-risk native aortic regurgitation
– Combined use of GLP-1 agonists + SGLT2 inhibitors in patients with T2D
– Cardiovascular effects of oral ketone ester treatment in patients with HFrEF
– Impact of optimal vs poor statin adherence after STEMI
– Transcatheter vs surgical treatment of aortic valve stenosis
– Empagliflozin after acute MI
– Use of artificial intelligence to predict AF
– Aspirin vs clopidogrel for long-term maintenance after coronary stenting
– Is excess apolipoprotein B associated with cardiovascular risk?
Download the Cardiology Research Review: Issue 165, with commentary by A/Prof John Amerena

